Keywords: Russia, Type 2 diabetes, Forecasts, Decision Resources, Bristol-Myers, AstraZeneca, Dapagliflozin, Johnson & Johnson, Canagliflozin

Russia’s type 2 diabetes drug market will grow to $1.7 billion in 2015

Article | 13 October 2011

Print This

Russia’s type 2 diabetes drug market will grow more than seven percent annually from $1.2 billion in 2010 to $1.7 billion in 2015. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in